Your session is about to expire
← Back to Search
Radiation
MRI-guided FM for Prostate Cancer (FLIP Trial)
N/A
Waitlist Available
Led By Peter Chung, MD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights
FLIP Trial Summary
This trial is designed to compare the accuracy of two types of images in guiding the placement of fiducial markers within a tumor.
Eligible Conditions
- Prostate Cancer
FLIP Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Magnetic Resonance Imaging
Secondary outcome measures
To evaluate MRI methods for the characterization of tissue oxygenation.
To evaluate the effect of neoadjuvant hormone therapy on tissue oxygenation.
To measure the needle targeting accuracy of the MRI-guided technique.
+1 moreFLIP Trial Design
2Treatment groups
Active Control
Group I: MRI-guided FMActive Control1 Intervention
Group II: TRUS-guided FMActive Control1 Intervention
Find a Location
Who is running the clinical trial?
University Health Network, TorontoLead Sponsor
1,468 Previous Clinical Trials
484,502 Total Patients Enrolled
63 Trials studying Prostate Cancer
15,383 Patients Enrolled for Prostate Cancer
Princess Margaret Hospital, CanadaOTHER
119 Previous Clinical Trials
39,042 Total Patients Enrolled
9 Trials studying Prostate Cancer
9,899 Patients Enrolled for Prostate Cancer
Peter Chung, MDPrincipal InvestigatorUniversity Health Network, Toronto
3 Previous Clinical Trials
309 Total Patients Enrolled
1 Trials studying Prostate Cancer
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are taking medication to prevent blood clots and cannot stop taking it before the procedure, which may involve needles.You are allergic to latex.You have a strong fear of enclosed spaces (claustrophobia) that significantly affects your ability to participate in the study.
Research Study Groups:
This trial has the following groups:- Group 1: MRI-guided FM
- Group 2: TRUS-guided FM
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any available slots for prospective participants in this clinical experiment?
"According to clinicaltrials.gov, this trial has ceased its recruitment of candidates; the original post was on June 1 2008 and it was last modified on October 20 2022. Despite being no longer active, there are 1321 other trials currently recruiting patients."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger